Bogota Will Allocate 800 Million Pesos to Finance Medical Cannabis Projects

The most interesting research cannabis projects in Bogota, Colombia, will be financed by the government. The Mayor’s Office of Bogota, through the Agency for Higher Education, Science, and Technology (Atenea), opened the first call to finance research projects on cannabis for its medicinal, therapeutic, and cosmetic applications. Those interested in participating may submit their projects by July 10th.

The call for cannabis projects has resources for $176,431 (800 million pesos) to finance scientific research projects, production, and industrialization of cannabis for medicinal, cosmetic, and industrial use, developed by technological development and innovation groups, belonging to universities or research centers, located in the Capital District, with certified experience in cannabis research, recognized by the National System of Science, Technology, and Innovation (MinCiencias) and duly registered companies, whose productive, processing or marketing activities are framed in the cannabis sector.

If you want to find more details about the financing in Bogota of cannabis projects and to find the most important cannabis news of the day, download for free the Hemp.im mobile app, available for both Android and iOS devices

It is expected that the research cannabis projects presented will have some degree of progress in their development

“This first call for proposals will be the starting engine to promote research in the cannabis industry towards medicinal use, the economy that revolves around this product, health, and the quality of life of millions of Bogota residents who will benefit from the results of this research,” explained José María Roldán, director of the Atenea agency.

It is expected that the research cannabis projects presented will have some degree of progress in their development in topics such as the consolidation of the production of knowledge of cannabis and its derivatives, its application in the industry, and its uses in health among other benefits, as well as the improvement of the understanding and use of the cannabis plant and its derivatives from research.

“There is still a great gap in knowledge about many medical, scientific, and therapeutic applications of cannabis, which opens a great opportunity for the development of research, from the local level, that contributes to the world of science, medicine, and industry, and accelerate the economy of the city,” said Roldan, who also added that for the choice of projects will be valued in linking women, newly graduated doctors funded with public resources and master and doctoral students.

__

(Featured image by SeaweedJeezus via Pixabay)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Semana, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.